Total Payments
$408,918
2024 Payments
$70,655
Companies
3
Transactions
211
Medicare Patients
6,566
Medicare Billing
$186,397
Payment Breakdown by Category
Consulting$408,148 (99.8%)
Travel$749.70 (0.2%)
Food & Beverage$20.37 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $408,148 | 203 | 99.8% |
| Travel and Lodging | $749.70 | 7 | 0.2% |
| Food and Beverage | $20.37 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $270,337 | 143 | $0 (2024) |
| Shire North American Group Inc | $138,560 | 67 | $0 (2019) |
| Novo Nordisk Inc | $20.37 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $70,655 | 42 | Takeda Pharmaceuticals U.S.A., Inc. ($70,635) |
| 2023 | $40,961 | 21 | Takeda Pharmaceuticals U.S.A., Inc. ($40,961) |
| 2022 | $63,362 | 34 | Takeda Pharmaceuticals U.S.A., Inc. ($63,362) |
| 2021 | $46,660 | 23 | Takeda Pharmaceuticals U.S.A., Inc. ($46,660) |
| 2020 | $48,720 | 24 | Takeda Pharmaceuticals U.S.A., Inc. ($48,720) |
| 2019 | $47,320 | 24 | Shire North American Group Inc ($47,320) |
| 2018 | $46,320 | 19 | Shire North American Group Inc ($46,320) |
| 2017 | $44,920 | 24 | Shire North American Group Inc ($44,920) |
All Payment Transactions
211 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,230.00 | General |
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,230.00 | General |
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 12/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 12/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,230.00 | General |
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,230.00 | General |
| 10/23/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.37 | General |
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,230.00 | General |
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,230.00 | General |
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,115.00 | General |
| 10/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,230.00 | General |
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,230.00 | General |
| 08/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 08/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,230.00 | General |
| 08/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,230.00 | General |
| 08/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 07/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,230.00 | General |
| 07/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,230.00 | General |
| 07/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 07/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,678 | 2,606 | $156,785 | $49,762 |
| 2022 | 29 | 1,529 | 2,393 | $140,101 | $44,218 |
| 2021 | 31 | 1,753 | 2,840 | $164,487 | $52,914 |
| 2020 | 28 | 1,606 | 2,548 | $139,093 | $39,504 |
Total Patients
6,566
Total Services
10,387
Medicare Billing
$186,397
Procedure Codes
117
All Medicare Procedures & Services
117 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 93 | 93 | $34,851 | $11,589 | 33.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 110 | 136 | $50,007 | $10,164 | 20.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 351 | 591 | $6,228 | $4,949 | 79.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 38 | $19,746 | $4,667 | 23.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $5,279 | $3,390 | 64.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 142 | 155 | $4,960 | $2,023 | 40.8% |
| 85610 | Blood test, clotting time | Office | 2023 | 58 | 463 | $4,514 | $1,945 | 43.1% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 166 | 225 | $4,725 | $1,859 | 39.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 114 | 171 | $3,292 | $1,295 | 39.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 105 | 129 | $3,128 | $1,220 | 39.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 14 | 15 | $1,579 | $1,132 | 71.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 25 | $6,536 | $1,123 | 17.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 81 | 89 | $2,336 | $921.15 | 39.4% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 97 | 119 | $1,904 | $754.46 | 39.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 22 | $1,208 | $658.02 | 54.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 21 | 41 | $2,111 | $391.98 | 18.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $703.50 | $388.83 | 55.3% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 38 | 42 | $609.00 | $233.21 | 38.3% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 38 | 42 | $535.50 | $209.31 | 39.1% |
| 80076 | Liver function blood test panel | Office | 2023 | 18 | 19 | $384.75 | $152.19 | 39.6% |
| 82248 | Bilirubin level, direct | Office | 2023 | 21 | 24 | $300.00 | $118.08 | 39.4% |
| 84450 | Liver enzyme (sgot), level | Office | 2023 | 14 | 23 | $299.00 | $116.84 | 39.1% |
| 84460 | Liver enzyme (sgpt), level | Office | 2023 | 15 | 22 | $291.50 | $114.18 | 39.2% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 15 | 17 | $534.75 | $84.32 | 15.8% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 17 | 20 | $195.00 | $77.00 | 39.5% |
About Dr. Amanda Lovold, DO
Dr. Amanda Lovold, DO is a Family Medicine healthcare provider based in St Cloud, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2008. The National Provider Identifier (NPI) number assigned to this provider is 1821252800.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amanda Lovold, DO has received a total of $408,918 in payments from pharmaceutical and medical device companies, with $70,655 received in 2024. These payments were reported across 211 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($408,148).
As a Medicare-enrolled provider, Lovold has provided services to 6,566 Medicare beneficiaries, totaling 10,387 services with total Medicare billing of $186,397. Data is available for 4 years (2020–2023), covering 117 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location St Cloud, MN
- Active Since 07/18/2008
- Last Updated 08/26/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1821252800
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in St Cloud
Dr. Michael Schmitz, D.o, D.O
Family Medicine — Payments: $137.54
Family Medicine $137.54
Dennis Peterson, M.d, M.D
Family Medicine — Payments: $50.00
Family Medicine $50.00
Patrick Lalley, Md, MD
Family Medicine — Payments: $35.37
Family Medicine $35.37
Kevin Donnelly, M.d, M.D
Family Medicine — Payments: $28.81
Family Medicine $28.81
Janet Handrigan, Md, MD
Family Medicine — Payments: $20.37
Family Medicine $20.37
Daniel Smith, M.d, M.D
Family Medicine — Payments: $15.04
Family Medicine $15.04